Renovaro Inc. - Common Stock (NQ: RENB )
0.6207
+0.0495
(+8.67%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 6, 2024
Add to My Watchlist
Press Releases about Renovaro Inc. - Common Stock
![](https://ml.globenewswire.com/media/bb458790-0f0d-47a3-861c-4cba6d6ae089/small/rgb-renovaro-logo-with-word-mark-png.png)
Renovaro, Inc. Announces $10 million in Equity Committed
June 14, 2024
From Renovaro Inc
Via GlobeNewswire
Impressive Short Squeeze Triggered for Cancer Immunotherapy Company Renovaro, Inc. (NASDAQ: RENB)
June 10, 2024
Via Get News
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
![](https://ml.globenewswire.com/media/bb458790-0f0d-47a3-861c-4cba6d6ae089/small/rgb-renovaro-logo-with-word-mark-png.png)
![](https://www.financialnewsmedia.com/wp-content/uploads/2021/06/FNM-GA-Logo1-1.jpg)
![](https://ml.globenewswire.com/media/f326183f-8829-42af-8851-525b1d7503ed/small/finacialnews-logo-final-01-2-png.png)
![](https://ml.globenewswire.com/media/bb458790-0f0d-47a3-861c-4cba6d6ae089/small/rgb-renovaro-logo-with-word-mark-png.png)
![](https://ml.globenewswire.com/media/bb458790-0f0d-47a3-861c-4cba6d6ae089/small/rgb-renovaro-logo-with-word-mark-png.png)
![](https://ml.globenewswire.com/media/bb458790-0f0d-47a3-861c-4cba6d6ae089/small/rgb-renovaro-logo-with-word-mark-png.png)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/bb458790-0f0d-47a3-861c-4cba6d6ae089/small/rgb-renovaro-logo-with-word-mark-png.png)
![](https://ml.globenewswire.com/media/25c79e82-0148-4a7e-beb5-e0c67d2e108f/small/main-png.png)
![](https://mms.businesswire.com/media/20240213814468/en/1164042/5/July_30%2C_2021_-_ROSEN_LOGO.jpg)
![](https://ml.globenewswire.com/media/25c79e82-0148-4a7e-beb5-e0c67d2e108f/small/main-png.png)
![](https://ml.globenewswire.com/media/25c79e82-0148-4a7e-beb5-e0c67d2e108f/small/main-png.png)
Patients with Swelling Disorder See New Gene Therapy as Godsend
February 07, 2024
![](https://ml.globenewswire.com/media/25c79e82-0148-4a7e-beb5-e0c67d2e108f/small/main-png.png)
Via GlobeNewswire
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Releases CEO Shareholder Message
January 16, 2024
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.